カテゴリー： Market Monitor Global, 世界, 医療/バイオ

IPVワクチンの世界市場見通し2023年-2029年

◆英語タイトル：IPV Vaccine Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8522 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：72 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global IPV Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるのIPVワクチン市場規模と予測を収録しています。・世界のIPVワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のIPVワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のIPVワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「Mahoney株」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

IPVワクチンのグローバル主要企業は、GlaxoSmithKline Plc、 Sanofi S.A、 Serum Institute of India Pvt. Ltd.、 PT Bio Farma、 AJ Vaccinesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、IPVワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のIPVワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のIPVワクチン市場：タイプ別市場シェア、2022年
・Mahoney株、MEF1株、Saukett株

世界のIPVワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のIPVワクチン市場：用途別市場シェア、2022年
・私的流通チャネル、公的流通チャネル

世界のIPVワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のIPVワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるIPVワクチンのグローバル売上、2018年-2023年
・主要企業におけるIPVワクチンのグローバル売上シェア、2022年
・主要企業におけるIPVワクチンのグローバル販売量、2018年-2023年
・主要企業におけるIPVワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
GlaxoSmithKline Plc、 Sanofi S.A、 Serum Institute of India Pvt. Ltd.、 PT Bio Farma、 AJ Vaccines

*************************************************************

・調査・分析レポートの概要
IPVワクチン市場の定義
市場セグメント
世界のIPVワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のIPVワクチン市場規模
世界のIPVワクチン市場規模：2022年 VS 2029年
世界のIPVワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのIPVワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のIPVワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：Mahoney株、MEF1株、Saukett株
IPVワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：私的流通チャネル、公的流通チャネル
IPVワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別IPVワクチン市場規模 2022年と2029年
地域別IPVワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline Plc、 Sanofi S.A、 Serum Institute of India Pvt. Ltd.、 PT Bio Farma、 AJ Vaccines
...

This report aims to provide a comprehensive presentation of the global market for IPV Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IPV Vaccine. This report contains market size and forecasts of IPV Vaccine in global, including the following market information:
Global IPV Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global IPV Vaccine Market Sales, 2018-2023, 2024-2029, (Units)
Global top five IPV Vaccine companies in 2022 (%)
The global IPV Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Mahoney Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of IPV Vaccine include GlaxoSmithKline Plc, Sanofi S.A, Serum Institute of India Pvt. Ltd., PT Bio Farma and AJ Vaccines, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IPV Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IPV Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global IPV Vaccine Market Segment Percentages, by Type, 2022 (%)
Mahoney
MEF1
Saukett
Global IPV Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global IPV Vaccine Market Segment Percentages, by Application, 2022 (%)
Private Distribution Channel
Public Distribution Channel
Global IPV Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global IPV Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IPV Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies IPV Vaccine revenues share in global market, 2022 (%)
Key companies IPV Vaccine sales in global market, 2018-2023 (Estimated), (Units)
Key companies IPV Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline Plc
Sanofi S.A
Serum Institute of India Pvt. Ltd.
PT Bio Farma
AJ Vaccines
Outline of Major Chapters:
Chapter 1: Introduces the definition of IPV Vaccine, market overview.
Chapter 2: Global IPV Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of IPV Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of IPV Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global IPV Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 IPV Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IPV Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IPV Vaccine Overall Market Size
2.1 Global IPV Vaccine Market Size: 2022 VS 2029
2.2 Global IPV Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global IPV Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top IPV Vaccine Players in Global Market
3.2 Top Global IPV Vaccine Companies Ranked by Revenue
3.3 Global IPV Vaccine Revenue by Companies
3.4 Global IPV Vaccine Sales by Companies
3.5 Global IPV Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 IPV Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers IPV Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 IPV Vaccine Players in Global Market
3.8.1 List of Global Tier 1 IPV Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 IPV Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global IPV Vaccine Market Size Markets, 2022 & 2029
4.1.2 Mahoney
4.1.3 MEF1
4.1.4 Saukett
4.2 By Type – Global IPV Vaccine Revenue & Forecasts
4.2.1 By Type – Global IPV Vaccine Revenue, 2018-2023
4.2.2 By Type – Global IPV Vaccine Revenue, 2024-2029
4.2.3 By Type – Global IPV Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global IPV Vaccine Sales & Forecasts
4.3.1 By Type – Global IPV Vaccine Sales, 2018-2023
4.3.2 By Type – Global IPV Vaccine Sales, 2024-2029
4.3.3 By Type – Global IPV Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global IPV Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global IPV Vaccine Market Size, 2022 & 2029
5.1.2 Private Distribution Channel
5.1.3 Public Distribution Channel
5.2 By Application – Global IPV Vaccine Revenue & Forecasts
5.2.1 By Application – Global IPV Vaccine Revenue, 2018-2023
5.2.2 By Application – Global IPV Vaccine Revenue, 2024-2029
5.2.3 By Application – Global IPV Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global IPV Vaccine Sales & Forecasts
5.3.1 By Application – Global IPV Vaccine Sales, 2018-2023
5.3.2 By Application – Global IPV Vaccine Sales, 2024-2029
5.3.3 By Application – Global IPV Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global IPV Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global IPV Vaccine Market Size, 2022 & 2029
6.2 By Region – Global IPV Vaccine Revenue & Forecasts
6.2.1 By Region – Global IPV Vaccine Revenue, 2018-2023
6.2.2 By Region – Global IPV Vaccine Revenue, 2024-2029
6.2.3 By Region – Global IPV Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global IPV Vaccine Sales & Forecasts
6.3.1 By Region – Global IPV Vaccine Sales, 2018-2023
6.3.2 By Region – Global IPV Vaccine Sales, 2024-2029
6.3.3 By Region – Global IPV Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America IPV Vaccine Revenue, 2018-2029
6.4.2 By Country – North America IPV Vaccine Sales, 2018-2029
6.4.3 US IPV Vaccine Market Size, 2018-2029
6.4.4 Canada IPV Vaccine Market Size, 2018-2029
6.4.5 Mexico IPV Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe IPV Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe IPV Vaccine Sales, 2018-2029
6.5.3 Germany IPV Vaccine Market Size, 2018-2029
6.5.4 France IPV Vaccine Market Size, 2018-2029
6.5.5 U.K. IPV Vaccine Market Size, 2018-2029
6.5.6 Italy IPV Vaccine Market Size, 2018-2029
6.5.7 Russia IPV Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries IPV Vaccine Market Size, 2018-2029
6.5.9 Benelux IPV Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia IPV Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia IPV Vaccine Sales, 2018-2029
6.6.3 China IPV Vaccine Market Size, 2018-2029
6.6.4 Japan IPV Vaccine Market Size, 2018-2029
6.6.5 South Korea IPV Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia IPV Vaccine Market Size, 2018-2029
6.6.7 India IPV Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America IPV Vaccine Revenue, 2018-2029
6.7.2 By Country – South America IPV Vaccine Sales, 2018-2029
6.7.3 Brazil IPV Vaccine Market Size, 2018-2029
6.7.4 Argentina IPV Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa IPV Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa IPV Vaccine Sales, 2018-2029
6.8.3 Turkey IPV Vaccine Market Size, 2018-2029
6.8.4 Israel IPV Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia IPV Vaccine Market Size, 2018-2029
6.8.6 UAE IPV Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline Plc
7.1.1 GlaxoSmithKline Plc Company Summary
7.1.2 GlaxoSmithKline Plc Business Overview
7.1.3 GlaxoSmithKline Plc IPV Vaccine Major Product Offerings
7.1.4 GlaxoSmithKline Plc IPV Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Plc Key News & Latest Developments
7.2 Sanofi S.A
7.2.1 Sanofi S.A Company Summary
7.2.2 Sanofi S.A Business Overview
7.2.3 Sanofi S.A IPV Vaccine Major Product Offerings
7.2.4 Sanofi S.A IPV Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi S.A Key News & Latest Developments
7.3 Serum Institute of India Pvt. Ltd.
7.3.1 Serum Institute of India Pvt. Ltd. Company Summary
7.3.2 Serum Institute of India Pvt. Ltd. Business Overview
7.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Major Product Offerings
7.3.4 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Serum Institute of India Pvt. Ltd. Key News & Latest Developments
7.4 PT Bio Farma
7.4.1 PT Bio Farma Company Summary
7.4.2 PT Bio Farma Business Overview
7.4.3 PT Bio Farma IPV Vaccine Major Product Offerings
7.4.4 PT Bio Farma IPV Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 PT Bio Farma Key News & Latest Developments
7.5 AJ Vaccines
7.5.1 AJ Vaccines Company Summary
7.5.2 AJ Vaccines Business Overview
7.5.3 AJ Vaccines IPV Vaccine Major Product Offerings
7.5.4 AJ Vaccines IPV Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 AJ Vaccines Key News & Latest Developments
8 Global IPV Vaccine Production Capacity, Analysis
8.1 Global IPV Vaccine Production Capacity, 2018-2029
8.2 IPV Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global IPV Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IPV Vaccine Supply Chain Analysis
10.1 IPV Vaccine Industry Value Chain
10.2 IPV Vaccine Upstream Market
10.3 IPV Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 IPV Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of IPV Vaccine in Global Market
Table 2. Top IPV Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global IPV Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global IPV Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global IPV Vaccine Sales by Companies, (Units), 2018-2023
Table 6. Global IPV Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers IPV Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers IPV Vaccine Product Type
Table 9. List of Global Tier 1 IPV Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IPV Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global IPV Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global IPV Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global IPV Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global IPV Vaccine Sales (Units), 2018-2023
Table 15. By Type - Global IPV Vaccine Sales (Units), 2024-2029
Table 16. By Application – Global IPV Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global IPV Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global IPV Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global IPV Vaccine Sales (Units), 2018-2023
Table 20. By Application - Global IPV Vaccine Sales (Units), 2024-2029
Table 21. By Region – Global IPV Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global IPV Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global IPV Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global IPV Vaccine Sales (Units), 2018-2023
Table 25. By Region - Global IPV Vaccine Sales (Units), 2024-2029
Table 26. By Country - North America IPV Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America IPV Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America IPV Vaccine Sales, (Units), 2018-2023
Table 29. By Country - North America IPV Vaccine Sales, (Units), 2024-2029
Table 30. By Country - Europe IPV Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe IPV Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe IPV Vaccine Sales, (Units), 2018-2023
Table 33. By Country - Europe IPV Vaccine Sales, (Units), 2024-2029
Table 34. By Region - Asia IPV Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia IPV Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia IPV Vaccine Sales, (Units), 2018-2023
Table 37. By Region - Asia IPV Vaccine Sales, (Units), 2024-2029
Table 38. By Country - South America IPV Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America IPV Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America IPV Vaccine Sales, (Units), 2018-2023
Table 41. By Country - South America IPV Vaccine Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa IPV Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa IPV Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa IPV Vaccine Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa IPV Vaccine Sales, (Units), 2024-2029
Table 46. GlaxoSmithKline Plc Company Summary
Table 47. GlaxoSmithKline Plc IPV Vaccine Product Offerings
Table 48. GlaxoSmithKline Plc IPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GlaxoSmithKline Plc Key News & Latest Developments
Table 50. Sanofi S.A Company Summary
Table 51. Sanofi S.A IPV Vaccine Product Offerings
Table 52. Sanofi S.A IPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Sanofi S.A Key News & Latest Developments
Table 54. Serum Institute of India Pvt. Ltd. Company Summary
Table 55. Serum Institute of India Pvt. Ltd. IPV Vaccine Product Offerings
Table 56. Serum Institute of India Pvt. Ltd. IPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Serum Institute of India Pvt. Ltd. Key News & Latest Developments
Table 58. PT Bio Farma Company Summary
Table 59. PT Bio Farma IPV Vaccine Product Offerings
Table 60. PT Bio Farma IPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. PT Bio Farma Key News & Latest Developments
Table 62. AJ Vaccines Company Summary
Table 63. AJ Vaccines IPV Vaccine Product Offerings
Table 64. AJ Vaccines IPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. AJ Vaccines Key News & Latest Developments
Table 66. IPV Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 67. Global IPV Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global IPV Vaccine Production by Region, 2018-2023 (Units)
Table 69. Global IPV Vaccine Production by Region, 2024-2029 (Units)
Table 70. IPV Vaccine Market Opportunities & Trends in Global Market
Table 71. IPV Vaccine Market Drivers in Global Market
Table 72. IPV Vaccine Market Restraints in Global Market
Table 73. IPV Vaccine Raw Materials
Table 74. IPV Vaccine Raw Materials Suppliers in Global Market
Table 75. Typical IPV Vaccine Downstream
Table 76. IPV Vaccine Downstream Clients in Global Market
Table 77. IPV Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. IPV Vaccine Segment by Type in 2022
Figure 2. IPV Vaccine Segment by Application in 2022
Figure 3. Global IPV Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global IPV Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global IPV Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. IPV Vaccine Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by IPV Vaccine Revenue in 2022
Figure 9. By Type - Global IPV Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global IPV Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global IPV Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global IPV Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global IPV Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global IPV Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global IPV Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global IPV Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global IPV Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global IPV Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global IPV Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global IPV Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America IPV Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America IPV Vaccine Sales Market Share, 2018-2029
Figure 23. US IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe IPV Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe IPV Vaccine Sales Market Share, 2018-2029
Figure 28. Germany IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia IPV Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia IPV Vaccine Sales Market Share, 2018-2029
Figure 37. China IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America IPV Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America IPV Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa IPV Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa IPV Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE IPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global IPV Vaccine Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production IPV Vaccine by Region, 2022 VS 2029
Figure 54. IPV Vaccine Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ IPVワクチンの世界市場見通し2023年-2029年(IPV Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

IPVワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp